Daniel Dornbusch, MBA

Chief Executive Officer

Mr. Dornbusch has worked in the biotechnology industry for over 20 years for large pharmaceutical, small biotechnology, diagnostics and specialty commercialization companies in business development, mergers and acquisitions, marketing, sales, commercial strategy, and product development. Daniel most recently served as founder and CEO of Acteris, Inc., an immunoncology company located in San Francisco.

Previous to Acteris, Daniel was the Chief Commercial Officer at Nodality, Inc., a therapeutic development company focused in immunology and oncology and completed transactions in immunology, oncology and immunoncology. Daniel began his career at Novartis in business development and later assumed responsibility as the Commercial Director of Latin America and the Western United States for the Diagnostics Division. Before Novartis, Daniel held roles in business development at Cerimon Pharmaceuticals Inc., led business development and sales for NMCR, an oncology strategy arm of AmerisourceBergen, and led a hematology marketing team at Genentech, Inc. Daniel started his biotechnology career at the Genzyme Corporation and served in various roles including business development, product management, and corporate development.

Daniel received his B.A. in Biology and English from Cornell University, M.S. from Tufts University School of Medicine and Emerson College, and M.B.A. from the Harvard Business School.